EA
ABMD

Emerald Acquisition’s Abiomed Inc ABMD Stock Holding History

Emerald Acquisition’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$25.2M Buy
196,206
+16,532
+9% +$1.98M 0.05% 436
2016
Q2 		$19.6M Buy
+179,674
New +$17.9M 0.03% 599

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Emerald Acquisition's ABMD Position: Q3 2016 in Review

Emerald Acquisition increased its Abiomed Inc (ABMD) stake by 9.2% in Q3 2016, buying an estimated $1.98M and bringing the position to 196,206 shares worth $25.2M. The position accounts for 0.05% of the portfolio, ranked #436.

Emerald Acquisition first reported a position in ABMD in Q2 2016 and has held it in 2 quarters since. 305 funds tracked by Wall St. Rank hold ABMD as of Q3 2016.

  • Emerald Acquisition held 196,206 shares of Abiomed Inc worth $25.2M as of Q3 2016.
  • Emerald Acquisition bought 16,532 Abiomed Inc shares in Q3 2016, an estimated $1.98M.
  • Abiomed Inc made up 0.05% of Emerald Acquisition's portfolio in Q3 2016, its #436 holding.
  • Emerald Acquisition first reported a position in Abiomed Inc in Q2 2016 and has held it in 2 quarters since.
  • 305 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.